
Jean-Yves Madec
Scientific Director Antimicrobial resistance – Anses
One Health Coordinator – Antimicrobial resistance – Institute of Immunology, Inflammation, Infectiology and Microbiology (I3M) – Inserm
Coordinator of the FAO Reference Center on Antimicrobial Resistance
One Health is recognised as an indisputable approach to tackle antimicrobial resistance (AMR).1 Yet, this concept fails to reach the innovation sector against AMR.
AMR in humans is linked to AMR in animals and the environment. Antimicrobial use in livestock and, increasingly, crops spreads drug-resistant bacteria. AMR threatens food security and development, and worsens global pressures such as climate change, biodiversity loss, pollution, pandemics, conflict and displacement.
As the United Nations notes, One Health requires stronger local, national and global action and a transdisciplinary, multisectoral response across humans, animals, plants and the environment, including the innovation sector.
Innovation against AMR is organised in silos
We urgently need new antimicrobials, but the innovation pipeline is dramatically declining. Appropriate economic models with new market incentives are on the table but still insufficiently effective. In addition to new treatments, we also need innovative solutions to better prevent and diagnose bacterial infections.
We urgently need new antimicrobials,
but the innovation pipeline is dramatically declining
All these needs are One Health needs since antibiotic use and AMR refer to the human, animal and environmental domains. Yet, we still face the paradox that whatever treatment, diagnostic or prevention is concerned, research and innovation strictly develop in silos, without synergies and mutual benefits (including financial ones) between sectors.
One Health innovation for diagnostics, prevention and treatment
In April 2026, the One Health Summit organised in Lyon under the Presidency of the French Republic brought together over 300 experts to propose concrete recommendations against AMR, such as launching an international sustainable bioeconomy AMR programme integrating the One Health approach and linking innovation, ecotoxicology and industrial development to support innovations.
ANRS Emerging infectious diseases/Inserm (ANRS MIE/Inserm) was nominated by the French Ministry of Research to follow-up the deliverables of the Lyon conference and will conduct initiatives in the frame of the Quadripartite (WHO, FAO, WOAH and UNEP) to progress on a multisectoral (One Health) coordination of innovation against AMR, for the benefit of humanity, animals, plants, ecosystems and livelihood.
[1] Robinson TP, Bu DP, Carrique-Mas J, et al. Antibiotic resistance is the quintessential One Health issue. Trans R Soc Trop Med Hyg. 2016 Jul;110(7):377-80. doi: 10.1093/trstmh/trw048.
Global Cause